David J. Wambeke serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, David J. Wambeke has executed 3 insider transactions totaling $949.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 16, 2023 involved purchasing 20,000 shares valued at $49.2K.
David J. Wambeke currently holds 527,114 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David J. Wambeke has been a net buyer of DMAC stock. They have purchased $949.2K and sold $0 worth of shares.
David J. Wambeke's most recent insider trade was on Nov 16, 2023, when they purchased 20,000 shares at $2.46 per share.
Get notified when new Form 4 filings are submitted
| $3.91 |
| Discretionary |
| Apr 10, 2023 | DMAC | $750.0K | Purchase | 468,750 | $1.60 | Discretionary |